MX2017008277A - Solucion oftalmica acuosa. - Google Patents
Solucion oftalmica acuosa.Info
- Publication number
- MX2017008277A MX2017008277A MX2017008277A MX2017008277A MX2017008277A MX 2017008277 A MX2017008277 A MX 2017008277A MX 2017008277 A MX2017008277 A MX 2017008277A MX 2017008277 A MX2017008277 A MX 2017008277A MX 2017008277 A MX2017008277 A MX 2017008277A
- Authority
- MX
- Mexico
- Prior art keywords
- ophthalmic solution
- aqueous ophthalmic
- concentration
- aqueous
- diquafosol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C13/00—Assembling; Repairing; Cleaning
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente invención se relaciona con una solución oftálmica acuosa que comprende diquafosol o una sal del mismo a una concentración del 0.1% al 10% (p/v) y una clorhexidina a una concentración del 0.0001% al 0.1% (p/v).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014263003 | 2014-12-25 | ||
JP2015114595 | 2015-06-05 | ||
PCT/JP2015/086230 WO2016104704A1 (ja) | 2014-12-25 | 2015-12-25 | 水性点眼液 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017008277A true MX2017008277A (es) | 2017-10-02 |
Family
ID=56150716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017008277A MX2017008277A (es) | 2014-12-25 | 2015-12-25 | Solucion oftalmica acuosa. |
Country Status (13)
Country | Link |
---|---|
US (2) | US10278985B2 (es) |
JP (3) | JP6779614B2 (es) |
KR (3) | KR102330736B1 (es) |
AR (1) | AR105199A1 (es) |
BR (1) | BR112017013841A2 (es) |
CA (1) | CA2971689C (es) |
EA (1) | EA034517B1 (es) |
MX (1) | MX2017008277A (es) |
MY (1) | MY182507A (es) |
PH (1) | PH12017501096A1 (es) |
SG (1) | SG11201705138QA (es) |
TW (1) | TWI709405B (es) |
WO (1) | WO2016104704A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI709405B (zh) * | 2014-12-25 | 2020-11-11 | 日商參天製藥股份有限公司 | 水性點眼液及其應用 |
TWI711453B (zh) * | 2015-06-05 | 2020-12-01 | 日商參天製藥股份有限公司 | 抑制水性點眼液中之洛赫西定類的殘存率降低之方法 |
RU2742032C2 (ru) | 2015-06-05 | 2021-02-01 | Сантен Фармасьютикал Ко., Лтд. | Терапевтическое средство против сухости глаз, характеризуемое нанесением на глаза пациентов с сухостью глаз, носящих гибкие контактные линзы |
KR20220163519A (ko) * | 2018-02-28 | 2022-12-09 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물 |
CN117771172A (zh) * | 2019-08-27 | 2024-03-29 | 参天制药株式会社 | 含有地夸磷索或其盐、及聚乙烯吡咯烷酮的水性眼科用组合物 |
US11229549B2 (en) * | 2019-09-18 | 2022-01-25 | Vance M. Thompson | Tear transplantation and multi-part contact lens with absorbent portion |
KR102365008B1 (ko) | 2020-06-23 | 2022-02-23 | 주식회사태준제약 | 디쿠아포솔을 포함하는 점안 조성물 |
CN115996705A (zh) | 2020-06-23 | 2023-04-21 | 株式会社泰俊制药 | 包含地夸磷索的眼用组合物 |
KR102548710B1 (ko) | 2020-12-24 | 2023-06-28 | 주식회사 종근당 | 디쿠아포솔 또는 이의 약제학적으로 허용가능한 염과 토코페롤을 함유하는 건성안 예방 또는 치료용 약제학적 조성물 |
JP7230169B2 (ja) * | 2020-12-25 | 2023-02-28 | 参天製薬株式会社 | ジクアホソルまたはその塩、銀塩およびイオン性等張化剤を含有する水性点眼液 |
WO2024010040A1 (ja) * | 2022-07-06 | 2024-01-11 | ロート製薬株式会社 | 眼科組成物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09301858A (ja) | 1996-05-13 | 1997-11-25 | Senju Pharmaceut Co Ltd | グルコン酸クロルヘキシジン安定化水性薬剤 |
JPH10203960A (ja) * | 1997-01-24 | 1998-08-04 | Ofutekusu:Kk | 点眼液組成物 |
JPH1160505A (ja) | 1997-05-20 | 1999-03-02 | Senju Pharmaceut Co Ltd | 防腐組成物 |
JP2008222638A (ja) | 2007-03-13 | 2008-09-25 | Teika Seiyaku Kk | 油成分含有眼用組成物 |
JP2009073788A (ja) | 2007-09-21 | 2009-04-09 | Teika Seiyaku Kk | イソプロピルウノプロストン含有眼用組成物 |
JP5398452B2 (ja) * | 2008-09-30 | 2014-01-29 | 大正製薬株式会社 | 点眼剤 |
CN102470115B (zh) * | 2009-08-07 | 2014-04-30 | 日本乐敦制药株式会社 | 硅酮水凝胶隐形眼镜用眼科组合物 |
JP6047272B2 (ja) * | 2010-09-15 | 2016-12-21 | テイカ製薬株式会社 | 角膜上皮障害治療用点眼剤 |
MY161032A (en) * | 2010-12-28 | 2017-04-03 | Santen Pharmaceutical Co Ltd | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
KR20190002751A (ko) | 2012-03-26 | 2019-01-08 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 함유 점안액 |
TWI709405B (zh) | 2014-12-25 | 2020-11-11 | 日商參天製藥股份有限公司 | 水性點眼液及其應用 |
-
2015
- 2015-12-25 TW TW104143787A patent/TWI709405B/zh active
- 2015-12-25 KR KR1020187015734A patent/KR102330736B1/ko active IP Right Grant
- 2015-12-25 KR KR1020177014598A patent/KR101789019B1/ko active IP Right Grant
- 2015-12-25 CA CA2971689A patent/CA2971689C/en active Active
- 2015-12-25 EA EA201791467A patent/EA034517B1/ru not_active IP Right Cessation
- 2015-12-25 JP JP2015253360A patent/JP6779614B2/ja active Active
- 2015-12-25 BR BR112017013841-7A patent/BR112017013841A2/pt not_active Application Discontinuation
- 2015-12-25 MX MX2017008277A patent/MX2017008277A/es unknown
- 2015-12-25 WO PCT/JP2015/086230 patent/WO2016104704A1/ja active Application Filing
- 2015-12-25 MY MYPI2017000969A patent/MY182507A/en unknown
- 2015-12-25 KR KR1020177029478A patent/KR101867791B1/ko active IP Right Grant
- 2015-12-25 US US15/539,283 patent/US10278985B2/en active Active
- 2015-12-25 SG SG11201705138QA patent/SG11201705138QA/en unknown
-
2016
- 2016-06-29 AR ARP160101981A patent/AR105199A1/es unknown
-
2017
- 2017-06-13 PH PH12017501096A patent/PH12017501096A1/en unknown
-
2019
- 2019-03-13 US US16/351,661 patent/US10786526B2/en active Active
-
2020
- 2020-10-14 JP JP2020173120A patent/JP7128243B2/ja active Active
-
2022
- 2022-08-18 JP JP2022130503A patent/JP2022166223A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2971689C (en) | 2020-11-03 |
SG11201705138QA (en) | 2017-07-28 |
MY182507A (en) | 2021-01-25 |
JP2016210759A (ja) | 2016-12-15 |
PH12017501096A1 (en) | 2017-11-27 |
KR20170067900A (ko) | 2017-06-16 |
US10786526B2 (en) | 2020-09-29 |
CA2971689A1 (en) | 2016-06-30 |
JP2021008513A (ja) | 2021-01-28 |
JP7128243B2 (ja) | 2022-08-30 |
AR105199A1 (es) | 2017-09-13 |
KR102330736B1 (ko) | 2021-11-23 |
US20170348344A1 (en) | 2017-12-07 |
KR101867791B1 (ko) | 2018-06-15 |
KR20170118255A (ko) | 2017-10-24 |
TWI709405B (zh) | 2020-11-11 |
KR20180063381A (ko) | 2018-06-11 |
EA201791467A1 (ru) | 2017-11-30 |
EA034517B1 (ru) | 2020-02-17 |
US20190209599A1 (en) | 2019-07-11 |
KR101789019B1 (ko) | 2017-10-20 |
US10278985B2 (en) | 2019-05-07 |
WO2016104704A1 (ja) | 2016-06-30 |
BR112017013841A2 (pt) | 2018-06-19 |
TW201628626A (zh) | 2016-08-16 |
JP6779614B2 (ja) | 2020-11-04 |
JP2022166223A (ja) | 2022-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501096A1 (en) | Aqueous ophthalmic solution | |
CL2016003416A1 (es) | Herbicidas de piperidinona | |
PH12016501873A1 (en) | Anti-influenza b virus hemagglutinin antibodies and methods of use | |
IL262294A (en) | Ophthalmic preparations containing levodopa, an antioxidant and a liquid carrier | |
CL2019002733A1 (es) | Formulaciones de clorhidrato del ácido 1-amino-1-ciclopropanocarboxílico. | |
CL2019000049A1 (es) | Procesos para la preparación de oxipicolinamidas 4 - alkoxi - (acil o aquil). | |
PH12017501071A1 (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
ZA201800504B (en) | Thickening agent for aqueous systems, formulations containing same and uses thereof | |
TR201901228T4 (tr) | Vortioksetin piroglutamat. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
EA201791099A1 (ru) | Хинолин карбоксамиды для применения в лечении лейкоза | |
CL2017000927A1 (es) | Dispersiones acuosas estables de zinc fosfato | |
DK3634384T3 (da) | Levodopa-infusionsopløsning | |
EP3448432A4 (en) | TARGETED ADMINISTRATION OF AEROSOLS FROM MAGNETIZED ACTIVE SUBSTANCES | |
MX2020003768A (es) | Composiciones acuosas herbicidas y metodos para usar las mismas. | |
FR3030531B1 (fr) | Agent epaississant pour systemes aqueux, formulations le contenant et utilisations | |
UA108358U (uk) | Застосування похідних 2-амінооцтової кислоти як засобів протимікробної дії | |
EP3843779A4 (en) | AMINO ACID DETENDER AGENTS AS ANTIPROLIFERATIVE AGENTS | |
UA120519U (uk) | Використання похідних 4-амінобутанової кислоти як антиамнестичних засобів | |
CL2017000320S1 (es) | Porción de carrete. | |
MX2018002193A (es) | Metodo de uso de quinoxalinilo-piperazinamida. | |
UA101964U (uk) | Застосування декаметоксину як протимікробного засобу проти бактерій виду pseudomonas aeruginosa | |
UA92941U (uk) | Застосування декаметоксину як протимікробного засобу проти бактерій роду bulkholderia | |
UA107468U (uk) | 25,27-ди-(5-тіо-октилокси)калікс[4]арен-краун-6 | |
UA114708U (uk) | Тяговий привід електробуса |